
IndraLab
Statements
reach
"Taken together, these results demonstrated that MYSM1 depletion suppressed the breast cancer cell growth in mice.Given its pleiotropic biological functions, MYSM1 may be a potential therapeutic target for drug development against breast cancer, especially in endocrine resistant ERα-positive breast cancer."